Lista de obras -

A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans

artículo científico publicado en 2022

A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.

artículo científico publicado en 2016

Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.

artículo científico publicado en 2017

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.

artículo científico publicado en 2016

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

artículo científico publicado en 2015

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

artículo científico publicado en 2018

Auxin responses in mutants of the Arabidopsis CONSTITUTIVE PHOTOMORPHOGENIC9 signalosome.

artículo científico publicado en 2008

Basal cell carcinomas in a tertiary referral centre: a systematic analysis.

artículo científico publicado en 2014

Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.

artículo científico publicado en 2016

Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients.

artículo científico publicado en 2014

Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5

artículo científico publicado en 2022

Correction: Whole-Genome Analysis of the SHORT-ROOT Developmental Pathway in Arabidopsis.

artículo científico publicado en 2006

Curing advanced melanoma by 2025.

artículo científico publicado en 2015

CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets.

artículo científico publicado en 2017

Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?

artículo científico publicado en 2017

Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.

artículo científico publicado en 2015

Epigenetic impacts of ascorbate on human metastatic melanoma cells

artículo científico publicado en 2014

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

artículo científico publicado en 2017

HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma Patients.

artículo científico publicado en 2017

Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma.

artículo científico publicado en 2015

Hedgehog signaling in basal cell carcinoma.

artículo científico

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

artículo científico publicado en 2018

High-throughput RNA isolation technologies. New tools for high-resolution gene expression profiling in plant systems.

artículo científico publicado en 2005

Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching ⬇️

artículo científico publicado el 8 de marzo de 2013

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy

artículo científico publicado en 2016

MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition.

artículo científico publicado en 2017

MEK inhibition and immune responses in advanced melanoma.

artículo científico publicado en 2017

Melanoma immunotherapy: historical precedents, recent successes and future prospects.

artículo científico publicado en 2013

Melanoma's next top model, it is in the air.

artículo científico publicado en 2015

Metastatic melanoma moves on: translational science in the era of personalized medicine.

artículo científico publicado en 2017

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma

artículo científico publicado en 2015

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

artículo científico publicado en 2017

NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis.

artículo científico publicado en 2017

NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells

scientific article published on 10 September 2020

Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation

artículo científico publicado en 2015

New tools for the identification of developmentally regulated enhancer regions in embryonic and adult zebrafish.

artículo científico publicado en 2013

Noncutaneous Melanomas: A Single-Center Analysis.

artículo científico publicado en 2015

Novel Blood Vascular Endothelial Subtype-Specific Markers in Human Skin Unearthed by Single-Cell Transcriptomic Profiling

artículo científico publicado en 2022

Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations.

artículo científico publicado en 2015

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.

artículo científico publicado en 2016

Perturbing resistance: a network perspective

artículo científico publicado en 2016

Proteomic identification of a marker signature for MAPKi resistance in melanoma

scientific article published on 26 June 2019

Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma.

artículo científico publicado en 2016

Real-life experience with pegylated interferon and conventional interferon in adjuvant melanoma therapy

artículo científico publicado en 2013

Size-exclusion chromatography combined with DIA-MS enables deep proteome profiling of extracellular vesicles from melanoma plasma and serum

artículo científico publicado en 2024

Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer

artículo científico publicado en 2017

Sorafenib in melanoma

artículo científico

Systems biology.

artículo científico publicado en 2004

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure

artículo científico publicado en 2017

The auxin influx carrier LAX3 promotes lateral root emergence

article

The maternal transcriptome of the crustacean Parhyale hawaiensis is inherited asymmetrically to invariant cell lineages of the ectoderm and mesoderm

artículo científico publicado en 2013

The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition.

artículo científico publicado en 2017

To B-(RAF) or not to be

artículo científico publicado en 2014

miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.

artículo científico publicado en 2017

Lista de obras de

A DNA replication-independent function of pre-replication complex genes during cell invasion in C. elegans

A Transcriptionally Inactive ATF2 Variant Drives Melanomagenesis.

Activin promotes skin carcinogenesis by attraction and reprogramming of macrophages.

An exploratory study investigating the metabolic activity and local cytokine profile in patients with melanoma treated with pazopanib and paclitaxel.

Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanoma.

Author Correction: High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

Auxin responses in mutants of the Arabidopsis CONSTITUTIVE PHOTOMORPHOGENIC9 signalosome.

Basal cell carcinomas in a tertiary referral centre: a systematic analysis.

Co-existence of BRAF and NRAS driver mutations in the same melanoma cells results in heterogeneity of targeted therapy resistance.

Coexpression of SOX10/CD271 (p75(NTR)) and β-Galactosidase in Large to Giant Congenital Melanocytic Nevi of Pediatric Patients.

Correction: Tusup et al. Evaluation of the Interplay between the ADAR Editome and Immunotherapy in Melanoma. Non-Coding RNA 2021, 7, 5

Correction: Whole-Genome Analysis of the SHORT-ROOT Developmental Pathway in Arabidopsis.

Curing advanced melanoma by 2025.

CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets.

Does the distribution pattern of brain metastases during BRAF inhibitor therapy reflect phenotype switching?

Downregulation of the Ubiquitin Ligase RNF125 Underlies Resistance of Melanoma Cells to BRAF Inhibitors via JAK1 Deregulation.

Epigenetic impacts of ascorbate on human metastatic melanoma cells

Evaluation of clinicopathological factors in PD-1 response: derivation and validation of a prediction scale for response to PD-1 monotherapy

HLA-A*26 Is Correlated With Response to Nivolumab in Japanese Melanoma Patients.

Hedgehog pathway inhibitors promote adaptive immune responses in basal cell carcinoma.

Hedgehog signaling in basal cell carcinoma.

High-dimensional single-cell analysis predicts response to anti-PD-1 immunotherapy

High-throughput RNA isolation technologies. New tools for high-resolution gene expression profiling in plant systems.

Hypoxia Contributes to Melanoma Heterogeneity by Triggering HIF1α-Dependent Phenotype Switching ⬇️

Inhibiting Drivers of Non-mutational Drug Tolerance Is a Salvage Strategy for Targeted Melanoma Therapy

MAPK pathway in melanoma part II-secondary and adaptive resistance mechanisms to BRAF inhibition.

MEK inhibition and immune responses in advanced melanoma.

Melanoma immunotherapy: historical precedents, recent successes and future prospects.

Melanoma's next top model, it is in the air.

Metastatic melanoma moves on: translational science in the era of personalized medicine.

Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanoma

Multicenter, real-life experience with checkpoint inhibitors and targeted therapy agents in advanced melanoma patients in Switzerland

NGS-pipe: a flexible, easily extendable, and highly configurable framework for NGS analysis.

NRASQ61K melanoma tumor formation is reduced by p38-MAPK14 activation in zebrafish models and NRAS-mutated human melanoma cells

Naevus spilus-type congenital melanocytic naevus associated with a novel NRAS codon 61 mutation

New tools for the identification of developmentally regulated enhancer regions in embryonic and adult zebrafish.

Noncutaneous Melanomas: A Single-Center Analysis.

Novel Blood Vascular Endothelial Subtype-Specific Markers in Human Skin Unearthed by Single-Cell Transcriptomic Profiling

Nrf2 Activation Promotes Keratinocyte Survival during Early Skin Carcinogenesis via Metabolic Alterations.

PARP1 inhibitor olaparib (Lynparza) exerts synthetic lethal effect against ligase 4-deficient melanomas.

Perturbing resistance: a network perspective

Proteomic identification of a marker signature for MAPKi resistance in melanoma

Proteomics approaches to understanding mitogen-activated protein kinase inhibitor resistance in melanoma.

Real-life experience with pegylated interferon and conventional interferon in adjuvant melanoma therapy

Size-exclusion chromatography combined with DIA-MS enables deep proteome profiling of extracellular vesicles from melanoma plasma and serum

Small molecule promotes β-catenin citrullination and inhibits Wnt signaling in cancer

Sorafenib in melanoma

Systems biology.

Targeting endothelin receptor signalling overcomes heterogeneity driven therapy failure

The auxin influx carrier LAX3 promotes lateral root emergence

The maternal transcriptome of the crustacean Parhyale hawaiensis is inherited asymmetrically to invariant cell lineages of the ectoderm and mesoderm

The mitogen-activated protein kinase pathway in melanoma part I - Activation and primary resistance mechanisms to BRAF inhibition.

To B-(RAF) or not to be

miR-181a decelerates proliferation in cutaneous squamous cell carcinoma by targeting the proto-oncogene KRAS.